Gossamer Bio Inc. (GOSS) Misses Q1 EPS by 3c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $16.96 million versus the consensus estimate of $4.71 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Micron Technology (MU) call put ratio 1 call to 1 put into quarter results
• Tesla (TSLA) call put ratio 1.1 calls to 1 put on 3.3M options